Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
HealthcareAdd-on
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Sermonix License Lasofoxifene to Athira
Announced
HealthcareWashingtonOther
Deal Overview
Sermonix Pharmaceuticals and Athira Pharma entered a License Agreement effective December 18, 2025. The agreement grants Athira an exclusive license to develop, manufacture, commercialize, and otherwise exploit Sermonix’s rights to Lasofoxifene and products containing Lasofoxifene outside the Retained Territory.
The exhibit text ties the licensed oncology asset to Sermonix’s selective estrogen-receptor modulator Lasofoxifene and frames Athira’s development as including additional registrational trials after a specified milestone.
Key Details
- Transaction
- Athira Pharma acquires Sermonix Pharmaceuticals
Filed under
Powered by Tentt
Source healthcare deals in Washington for your firm
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Seven-figure funding deal secures Swindon site acquisition for medical products firm
HealthcareAdd-on
Quvara Medical→Becton Dickinson
Apr 15, 2026
Indiana hospital signs LOI to join Parkview Health
HealthcareIndianaMerger
Parkview Health→Witham Health Services
Apr 15, 2026
What Surgery Partners’ vascular acquisition means for the industry
HealthcareTENNESSEEAdd-on
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra completes acquisition of AI firm Oxipit - AuntMinnie
HealthcareAdd-on
Sectra→Oxipit
Apr 15, 2026